Cargando…

Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?

Hepatocellular carcinoma (HCC) represents the sixth most common cancer worldwide and the third most common cause of cancer-related death. One of the major problems faced by researchers and clinicians in this area is the lack of reliable disease biomarkers, which would allow for an earlier diagnosis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mocan, Tudor, Simão, André L., Castro, Rui E., Rodrigues, Cecília M. P., Słomka, Artur, Wang, Bingduo, Strassburg, Christian, Wöhler, Aliona, Willms, Arnulf G., Kornek, Miroslaw
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291267/ https://www.ncbi.nlm.nih.gov/pubmed/32443747 http://dx.doi.org/10.3390/jcm9051541

Ejemplares similares

Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?
por: Słomka, Artur, et al.
Publicado: (2022)

Liquid Biopsy in Organ Damage: small extracellular vesicle chip-based assessment of polytrauma
por: Wang, Bingduo, et al.
Publicado: (2023)

EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC
por: Słomka, Artur, et al.
Publicado: (2020)

Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?
por: Słomka, Artur, et al.
Publicado: (2018)

Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer
por: Piekuś-Słomka, Natalia, et al.
Publicado: (2023)

Extracellular Vesicle Profiling and Their Use as Potential Disease Specific Biomarker
por: Julich, Henrike, et al.
Publicado: (2014)

Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia
por: Willms, Arnulf, et al.
Publicado: (2016)

Small Extracellular Vesicles and Their Involvement in Cancer Resistance: An Up-to-Date Review
por: Słomka, Artur, et al.
Publicado: (2022)

Contemporary role of liver biopsy in hepatocellular carcinoma
por: Sparchez, Zeno, et al.
Publicado: (2018)

Are we winning the fight?
por: Damle, S. G.
Publicado: (2014)

Winning with liquid alternatives
por: Mains, Norman E
Publicado: (2014)

Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Refining Liver Biopsy in Hepatocellular Carcinoma: An In-Depth Exploration of Shifting Diagnostic and Therapeutic Applications
por: Spârchez, Zeno, et al.
Publicado: (2023)

Liquid biopsies, are we ready for prime time?
por: Normanno, Nicola, et al.
Publicado: (2023)

Use of a visceral protective layer prevents fistula development in open abdomen therapy: results from the European Hernia Society Open Abdomen Registry
por: Schaaf, Sebastian, et al.
Publicado: (2023)

Are we finally winning the war on unhealthy foods?
por: Westgarth, David
Publicado: (2021)

When women win, we all win—Call for a gendered global NCD agenda
por: Ngaruiya, Christine
Publicado: (2022)

Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?
por: Atherton, John J.
Publicado: (2012)

China and the European Union in Africa: win–win-lose or win–win-win?
por: Che, Dewei, et al.
Publicado: (2023)

Can We Ever Win with a Suprachoroidal Implant?
por: Au, Leon, et al.
Publicado: (2023)

Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
por: Minciacchi, V R, et al.
Publicado: (2017)

Trucut Biopsy vs FNAC of Pelvic Tumors-Who Wins the Match?
por: Kar, Asaranti, et al.
Publicado: (2018)

Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going
por: Mazzitelli, Carlotta, et al.
Publicado: (2023)

Win-win-win management: making winning partners out of every member of an organisation
por: Graff, Philippe
Publicado: (1993)

Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?
por: van der Laan, Pia, et al.
Publicado: (2021)

Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
por: Heredia-Soto, Victoria, et al.
Publicado: (2021)

Liquid Biopsy in Gastrointestinal Cancers: How Close Are We to Reaching the Clinic?
por: Earl, Julie, et al.
Publicado: (2023)

Surgical Treatment of Articular Cartilage Defects in the Knee: Are We Winning?
por: Memon, A. R., et al.
Publicado: (2012)

Liquid biopsies in myeloid malignancies
por: Abdulmawjood, Bilal, et al.
Publicado: (2019)

The Spirit of Competition: To Win or Not To Win
por: Szczepinska, Teresa, et al.
Publicado: (2013)

Editorial: Open Abdominal Treatment: How Much Evidence Do We Have?
por: Willms, Arnulf Gregor, et al.
Publicado: (2021)

Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand?
por: Perge, Pál, et al.
Publicado: (2022)

Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
por: Mirza, Sheefa, et al.
Publicado: (2023)

Viscoelastic tests in liver disease: where do we stand now?
por: Buliarca, Alina, et al.
Publicado: (2021)

The Truth About Win-Win Negotiating
por: Thompson, Leigh
Publicado: (2010)

Development and Validation of the Win-Win Scale
por: Zhang, Shan, et al.
Publicado: (2021)

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?
por: Obaro, Stephen K, et al.
Publicado: (2006)

Till we win: Indian's fight against the COVID-19 pandemic
Publicado: (2021)

Till We Win: India's Fight agnainst the COVID-19 Pandemic
por: Sharma, Rashmi
Publicado: (2021)

Ombuds’ corner: Compromise or “win-win” solution?
por: Vincent Vuillemin
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4vb5mmqf8b7eh06lbpdtki9gdc